Jefferies Group LLC Allakos Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Sep 21, 2023
BUY
$79.58 - $152.45 $2.93 Million - $5.61 Million
36,800 New
36,800 $5.15 Million
Q4 2020

Feb 16, 2021
BUY
$79.58 - $152.45 $1.7 Million - $3.25 Million
21,300 Added 137.42%
36,800 $5.15 Million
Q4 2019

Feb 13, 2020
SELL
$66.49 - $137.73 $1.56 Million - $3.24 Million
-23,500 Reduced 60.26%
15,500 $1.48 Million
Q3 2019

Nov 13, 2019
BUY
$31.0 - $89.73 $1.21 Million - $3.5 Million
39,000 New
39,000 $3.07 Million

Others Institutions Holding ALLK

# of Institutions
81
Shares Held
64.7M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $21.2M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email